Logo

Home

smallArrow

Stocks Screener

smallArrow

Nectar Lifesciences

Nectar Lifesciences Share Price

Nectar Lifesciences (INR)42.25-1.8   (-4.2%)

Exchange ScripsBSE532649NSENECLIFEISININE023H01027

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Nectar Lifesciences Performance

Market performance
Open price44.35
High48.24
Volumes3636822
Prev Close42.25
Low41.67
Closing date2024-09-20
Historical performance
1 Year High56.50
3 Year High56.50
5 Year High56.50
1 Year Low21.50
3 Year Low14.50
5 Year Low7.10

Nectar Lifesciences Fundamentals

Company Valuation
Market Cap
Market Cap (₹Cr)
741
Face Value
Face Value (₹)
1
P/E Ratio
P/E Ratio
189.72
Dividend Yield
Dividend Yield
N/A

Nectar Lifesciences Investment Returns

1 Year
68.7%
3 Years
45.2%
5 Years
198.6%
10 Years
1.2%

Nectar Lifesciences Technicals

IndicatorsValueSignal
5-DMA45.94Bearish
10-DMA49.24Bearish
20-DMA45.4Bearish
50-DMA36.75Bullish
100-DMA34.71Bullish
200-DMA34.5Bullish

Shareholding Pattern

FieldJun-2024Mar-2024Dec-2023Sep-2023Jun-2023
Promoters22222
Foreign Investors---------------
Domestic Investors22222
Public Investors5822759943607586028061579
Government11111

Nectar Lifesciences Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Other Income243531113114
Operating Profit1759106116991128
Interest9698947881120
Depreciation607591570603
Profit Before Tax183-424341-848
Consolidated Net Profit50-242250-733
Adjusted EPS----11-3

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Share Capital224224224224
Total Reserves10468104221065510396
Minority Interest------------
Total Non-Current Liabilities1415213129631264
Total Liabilities21836216862388023758
Capital Work in Progress658778851986
Total Assets21836216862388023758

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Cash Flow from Operating Activities22471337950214
Cash Flow from Investing Activities-170517166-286
Cash Flow from Financing Activitie-2054-1856-1194115
Net Cash Inflow / Outflow22-2-7742
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 189.72.
  • 3Y Stock Price CAGR of the stock is 13.9.
  • The stock has a beta of 0.9.
  • In the last financial year, the company had an EBITDA of ₹1759 Million.
  • The company generated revenue of ₹16841 Million in the previous financial year.

Nectar Lifesciences

42.25-1.8   (-4.2%)

Investment Amount: ₹ 2480
Current Value: ₹ 4225
Performence: 70.4%
P/L: ₹ 1745
Top Gainers
SymbolChange%
ITDCEM562.45(19%)
MARKSANS318.35(16%)
CONCORDBIO2601.1(16%)
MAGADSUGAR957.45(14%)
PRSMJOHNSN219.54(12%)
Top Losers
SymbolChange%
ROSSELLIND170.85(-73%)
SADHNANIQ59.21(-9%)
BHARATRAS11914.5(-7%)
PEARLPOLY42.08(-7%)
SAKSOFT276.15(-7%)
AGIIL1042.6(-6%)
GATECH1.17(-6%)
XTGLOBAL41.63(-6%)
Similar stocks

Panacea Biotec

▲ 62.2

314.09

August 20 - September 20

Concord Biotech

▲ 57.1

2601.1

August 20 - September 20

Marksans Pharma

▲ 44.3

318.35

August 20 - September 20

Syncom Formulations

▲ 39.5

22.71

August 20 - September 20

Wanbury

▲ 38.6

278.79

August 20 - September 20

Jubilant Pharmova

▲ 34.5

1206.1

August 20 - September 20

Brooks Laboratories

▲ 33.6

147.47

August 20 - September 20

Biofil Chem & Pharma

▲ 29.7

83.6

August 20 - September 20

Announcing Stock of the Month!

 

Phone

Registered Users

10 lacs

Google Rating

4.6